CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 85 enrolled
Drug / intervention
Wingman Crossing Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03403426
NCT03403426N/ACompleted
CompareCT.gov

A Non-Randomized Study Evaluating the Use of the ReFlow Medical Wingman Catheter to Cross Chronic Total Occlusions in Infrainguinal Peripheral ArTeries

ReFlow Medical, Inc.·interventional·Posted Jan 18, 2018·Updated Jan 7, 2021

In Brief

A clinical study evaluating Wingman Crossing Catheter for Chronic Total Occlusion of Artery of the Extremities. Completed, enrolled 85 participants across 1 site.

Detailed Summary

To evaluate the safety and effectiveness of the ReFlow Medical Wingman Catheter used to cross de novo or restenotic infrainguinal CTOs that cannot be crossed with a standard guidewire.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Total Occlusion of Artery of the Extremities
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 18, 2018
Enrollment StartFeb 13, 2018
Primary CompletionAug 8, 2019
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.5 years ago

Interventions

Wingman Crossing Catheterdevice

Endovascular CTO crossing